← back to search

Theresa Scognamiglio

Cornell University · US
Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research interests include Thyroid Cancer Diagnosis and Treatment, CAR-T cell therapy research, Thyroid and Parathyroid Surgery, and Salivary Gland Tumors Diagnosis and Treatment.
h-index
34
citations
3,511
works
182
NIH funding
primary concept
email

Recent publications

Safety and efficacy of AIC100 chimeric antigen receptor (CAR) T-cell therapy in patients with advanced thyroid cancers: Results from the phase 1 study.
Journal of Clinical Oncology 2024cited by 8position: middledoi
Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer
Nature 2022cited by 86position: middledoi
Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration
JCI Insight 2022cited by 25position: middledoi
NR4A3 Immunostain Is a Highly Sensitive and Specific Marker for Acinic Cell Carcinoma in Cytologic and Surgical Specimens
American Journal of Clinical Pathology 2021cited by 24position: lastdoi
PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid Cancer
Clinical Cancer Research 2020cited by 48position: middledoi
The role of the Milan System for Reporting Salivary Gland Cytopathology: A 5‐year institutional experience
Cancer Cytopathology 2018cited by 138position: middledoi
Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features
Thyroid 2017cited by 129position: middledoi
CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors
Clinical Cancer Research 2017cited by 98position: middledoi
Sonographic and cytologic differences of NIFTP from infiltrative or invasive encapsulated follicular variant of papillary thyroid carcinoma
Diagnostic Cytopathology 2017cited by 92position: lastdoi
Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression
eLife 2017cited by 62position: middledoi
Author response: Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression
2017cited by 0position: middledoi
The molecular features of tongue epithelium treated with the carcinogen 4-nitroquinoline-1-oxide and alcohol as a model for HNSCC
Carcinogenesis 2013cited by 61position: middledoi
A Panel of Four miRNAs Accurately Differentiates Malignant from Benign Indeterminate Thyroid Lesions on Fine Needle Aspiration
Clinical Cancer Research 2012cited by 156position: middledoi
Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules
Cancer 2012cited by 63position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Thomas J. Fahey · NewYork–Presbyterian Hospital5 papers (2012–2022)Rasa Zarnegar · Cornell University5 papers (2012–2022)Olivier Elemento · Cornell University4 papers (2012–2022)Irene M. Min · Houston Methodist3 papers (2017–2022)Rohan Bareja · NewYork–Presbyterian Hospital3 papers (2017–2022)Anvy Nguyen · Massachusetts General Hospital3 papers (2012–2017)Moonsoo M. Jin · Houston Methodist3 papers (2017–2024)Akanksha Verma · Sanjay Gandhi Post Graduate Institute of Medical Sciences3 papers (2017–2022)Dessislava Stefanova · Cornell University2 papers (2020–2022)Eleonora Riva · University of Ferrara2 papers (2017–2017)Viviana Anelli · NewYork–Presbyterian Hospital2 papers (2017–2017)Timothy M. Ullmann · Twitter (United States)2 papers (2020–2022)Katherine D. Gray · Memorial Sloan Kettering Cancer Center2 papers (2017–2020)Jacques A. Villefranc · University of Massachusetts Chan Medical School2 papers (2017–2017)Michael J. Crowley · Cornell University2 papers (2012–2012)Maureen D. Moore · Cooper University Hospital2 papers (2017–2022)Raúl Martinez-McFaline · Massachusetts Institute of Technology2 papers (2017–2017)Sagar Chhangawala · Electrical Geodesics (United States)2 papers (2017–2017)Momin T. Siddiqui · NewYork–Presbyterian Hospital2 papers (2018–2021)Yariv Houvras · Urologische Klinik München2 papers (2017–2017)